%0 Journal Article
%T 1044. Aztreonam (AZT) vs. Cephalosporin (CEP) Therapy for the Treatment of Gram-Negative Bacteremia
%J Archive of "Open Forum Infectious Diseases".
%D 2018
%R 10.1093/ofid/ofy210.881
%X The IDSA recommends use of AZT in patients with a confirmed beta-lactam allergy for nosocomial Gram-negative infections. Despite this recommendation, there is limited data to suggest AZT is inferior to cephalosporins (CEP) for the treatment of Gram-negative infections. This study aims to evaluate clinical outcomes in bacteremic patients treated with either AZT or CEP therapy
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254044/